X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (89) 89
index medicus (88) 88
humans (65) 65
cancer (45) 45
female (39) 39
male (36) 36
cell biology (33) 33
middle aged (32) 32
aged (31) 31
adult (29) 29
tumors (27) 27
aged, 80 and over (23) 23
mutation (22) 22
article (20) 20
patients (19) 19
biology (18) 18
clinical trials (18) 18
treatment outcome (17) 17
chemotherapy (16) 16
mutations (15) 15
neoplasms - drug therapy (15) 15
neoplasms - genetics (14) 14
neoplasms - pathology (14) 14
care and treatment (13) 13
chemistry (13) 13
metallurgy (13) 13
microbiology (13) 13
research (13) 13
studies (13) 13
tcga (13) 13
antineoplastic agents - administration & dosage (12) 12
beer (12) 12
biochemistry (12) 12
biochemistry & molecular biology (12) 12
cholangiocarcinoma (12) 12
compositions or test papers therefor (12) 12
condition-responsive control in microbiological orenzymological processes (12) 12
enzymology (12) 12
measuring or testing processes involving enzymes, nucleicacids or microorganisms (12) 12
mutation or genetic engineering (12) 12
processes of preparing such compositions (12) 12
spirits (12) 12
vinegar (12) 12
wine (12) 12
antineoplastic agents - therapeutic use (11) 11
expression (11) 11
gene expression (11) 11
genomics (11) 11
immunotherapy (11) 11
maximum tolerated dose (11) 11
medicine & public health (11) 11
animals (10) 10
antineoplastic agents - adverse effects (10) 10
gastroenterology & hepatology (10) 10
gemcitabine (10) 10
metastasis (10) 10
pancreatic cancer (10) 10
prognosis (10) 10
survival (10) 10
analysis (9) 9
breast-cancer (9) 9
cancer therapies (9) 9
databases, genetic (9) 9
drug administration schedule (9) 9
genes (9) 9
health aspects (9) 9
identification (9) 9
pharmacology & pharmacy (9) 9
bile duct neoplasms - genetics (8) 8
cholangiocarcinoma - genetics (8) 8
dna methylation (8) 8
dose-response relationship, drug (8) 8
genomes (8) 8
intrahepatic cholangiocarcinoma (8) 8
landscape (8) 8
medical prognosis (8) 8
medicine (8) 8
neoplasms. tumors. oncology. including cancer and carcinogens (8) 8
pharmacokinetics (8) 8
pharmacology/toxicology (8) 8
review (8) 8
the cancer genome atlas (8) 8
antineoplastic agents - pharmacokinetics (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
deoxyribonucleic acid--dna (7) 7
genome (7) 7
kinases (7) 7
melanoma (7) 7
molecular targeted therapy (7) 7
neoplasm staging (7) 7
neoplasms - metabolism (7) 7
peptides (7) 7
solid tumors (7) 7
therapy (7) 7
transcriptome (7) 7
young adult (7) 7
activation (6) 6
diagnosis (6) 6
disease progression (6) 6
drug therapy (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunotherapy, ISSN 1750-743X, 08/2018, Volume 10, Issue 11, pp. 971 - 986
The standard of care for early hepatobiliary cancers (HBC) includes surgical resection. Liver transplantations or locoregional therapies are beneficial in... 
ADVANCED HEPATOCELLULAR-CARCINOMA | LIVER-CANCER | SURGICAL-RESECTION | MEASLES-VACCINE VIRUS | PROSPECTIVE RANDOMIZED-TRIAL | LONG-TERM SURVIVAL | GALLBLADDER CANCER | DOUBLE-RESTRICTED ADENOVIRUS | GENE-THERAPY | IMMUNOLOGY | VESICULAR STOMATITIS-VIRUS
Journal Article
Cureus, ISSN 2168-8184, 07/2017, Volume 9, Issue 7, p. e1517
Breast cancer 1 antigen (BRCA 1) and breast cancer 2 antigen (BRCA2) genes play a significant role in deoxyribonucleic acid (DNA) repair by means of... 
Journal Article
Journal Article
Oncolytic virotherapy, ISSN 2253-1572, 2019, Volume 8, pp. 1 - 1
[This corrects the article on p. 11 in vol. 6, PMID: 28224120.]. 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 12, pp. 1164 - 1172
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 33, pp. 4877 - 4883
Purpose To compare the progression-free survival (PFS) using a treatment regimen selected by molecular profiling (MP) of a patient's tumor with the PFS for the... 
BREAST-CANCER | TRIAL | ONCOLOGY | MESSENGER-RNA EXPRESSION | PREDICT | OVARIAN-CANCER | CHEMOTHERAPY | Neoplasms - metabolism | Disease-Free Survival | Neoplasms - therapy | Pilot Projects | Humans | Middle Aged | Neoplasms - mortality | Adult | Female | Male | Aged | Gene Expression Profiling | Index Medicus
Journal Article
PLoS Genetics, ISSN 1553-7390, 02/2014, Volume 10, Issue 2, pp. e1004135 - e1004135
Author Summary Cholangiocarcinoma is a cancer that affects the bile ducts. Unfortunately, many patients diagnosed with cholangiocarcinoma have disease that... 
C-VIRUS-INFECTION | GROWTH-FACTOR RECEPTOR | BILIARY-TRACT CANCER | K-RAS MUTATIONS | RISK-FACTORS | GENETICS & HEREDITY | TUMOR-SUPPRESSOR GENE | HEPATITIS-C | PRIMARY SCLEROSING CHOLANGITIS | FLUKE-ASSOCIATED CHOLANGIOCARCINOMA | NEGATIVE BREAST-CANCER | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - genetics | Prognosis | Receptor, Fibroblast Growth Factor, Type 2 - metabolism | Humans | Transcriptome | Imidazoles - administration & dosage | Molecular Targeted Therapy | Receptor, Epidermal Growth Factor - metabolism | Pyridazines - administration & dosage | Quinazolines - administration & dosage | Receptor, Fibroblast Growth Factor, Type 2 - antagonists & inhibitors | Bile Duct Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Bile Ducts, Intrahepatic - pathology | Pyrimidines - administration & dosage | Signal Transduction - genetics | Cholangiocarcinoma - pathology | Protein Kinase Inhibitors | Cholangiocarcinoma - drug therapy | Cell Line, Tumor | Cholangiocarcinoma - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Bile Duct Neoplasms - pathology | Mutation | Genome, Human | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Sulfonamides - administration & dosage | Antimitotic agents | Analysis | Genomics | Research | Antineoplastic agents | Health aspects | Tumors | Index Medicus | Studies | Hepatitis | Substance abuse treatment | Genetic engineering | Genomes | Kinases | Gene expression | Patients | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1981 - 1987
Purpose We have previously shown that intensity-modulated radiotherapy (IMRT) can reduce dose to small bowel, bladder, and bone marrow compared with... 
Radiology | Hematology, Oncology and Palliative Medicine | Preoperative radiotherapy | Rectal cancer | Intensity-modulated radiation therapy | CLINICAL TARGET VOLUME | MEGAVOLTAGE COMPUTED-TOMOGRAPHY | WHOLE PELVIC RADIOTHERAPY | RADIATION-THERAPY | ACUTE HEMATOLOGIC TOXICITY | PHASE-II TRIAL | GYNECOLOGIC MALIGNANCIES | ONCOLOGY | CONCURRENT CHEMOTHERAPY | DOSE-VOLUME RELATIONSHIPS | PREOPERATIVE HELICAL TOMOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Intestines - radiation effects | Middle Aged | Male | Urinary Bladder - radiation effects | Radiotherapy, Intensity-Modulated - adverse effects | Aged, 80 and over | Adult | Female | Retrospective Studies | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Chemoradiotherapy - methods | Rectal Neoplasms - surgery | Radiotherapy, Intensity-Modulated - methods | Radiation Injuries - complications | Adenocarcinoma - drug therapy | Rectal Neoplasms - radiotherapy | Enteritis - etiology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Diarrhea - etiology | Radiotherapy, Conformal - adverse effects | Aged | Adenocarcinoma - surgery | Preoperative Period | Radiotherapy, Conformal - methods | Care and treatment | Research | Radiotherapy | Nuclear radiation | Oncology, Experimental | Cancer | Index Medicus | PATIENTS | DIARRHEA | DISEASE INCIDENCE | NEOPLASMS | RECTUM | BONE MARROW | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | ENTERITIS | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | SIDE EFFECTS
Journal Article
Human Pathology, ISSN 0046-8177, 2014, Volume 45, Issue 8, pp. 1630 - 1638
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2011, Volume 17, Issue 8, pp. 2502 - 2511
Journal Article
Bioinformatics, ISSN 1367-4803, 03/2019
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 442 - 442
Journal Article
Hepatology, ISSN 0270-9139, 06/2018, Volume 67, Issue 6, pp. 2338 - 2351
Primary sclerosing cholangitis (PSC) is a risk factor for cholangiocarcinoma (CCA) and gallbladder carcinoma (GBCa). Surveillance for GBCa is recommended, but... 
UNITED-STATES | CHOLANGIOCARCINOMA | DIAGNOSIS | HEPATOCELLULAR-CARCINOMA | SERUM CA-19-9 | RISK-FACTORS | LIVER-TRANSPLANTATION | MANAGEMENT | CLINICAL PRESENTATION | CIRRHOSIS | GASTROENTEROLOGY & HEPATOLOGY | Statistical analysis | Surveillance | Cholangitis | Medical records | Gallbladder | Hepatocellular carcinoma | Diagnosis | Survival | Cholangiocarcinoma | Index Medicus
Journal Article
Journal Article